Publication | Closed Access

Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

Breast OncologyOncologyCancer ManagementLow-dose Metronomic ChemotherapyPharmacologyMetronomic TherapyClinical OutcomesPharmacotherapyBreast CancerMetronomic ChemotherapyCancer TreatmentMedicineCancer Chemotherapy